$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
6 Health Care Dividend Stocks To By Hand Over Fist
10:48am, Monday, 11'th Dec 2023
This biotech giant remains a top stock for investors to buy and pays a solid 3.13% dividend.
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
01:48pm, Sunday, 10'th Dec 2023
Chimeric antigen receptor T-cell medicines could have more risks than previously known. Novartis' drug Kymriah is going to be under the most scrutiny for now.
Will Bristol Myers' (BMY) Efforts to Boost Portfolio be Enough?
01:32pm, Friday, 08'th Dec 2023
Shares of Bristol Myers (BMY) have been impacted by pipeline bottlenecks and its key drugs face generic competition. We take a look at the company's efforts to counter these.
Bristol Myers adds $3 billion to share buyback program to boost total to about $5 billion
06:34am, Thursday, 07'th Dec 2023
Bristol Myers Squibb Co. BMY, -0.70% announced an additional $3 billion share buyback program on Thursday, boosting the full authorization to about $5 billion. The stock rose 1% premarket but is down
Bristol Myers Squibb raises dividend by 5.3%
05:14pm, Wednesday, 06'th Dec 2023
Bristol Myers Squibb Co. BMY, -0.70% said late Wednesday that its board has declared a quarterly dividend of 60 cents a share, a 5.3% increase over last year's dividend of 57 cents a share. The divide
Bristol Myers' (BMY) Opdivo sBLA Gets FDA's Priority Review
11:17am, Wednesday, 06'th Dec 2023
Bristol Myers (BMY) announces that the FDA has accepted its sBLA for Opdivo to treat first-line adult patients with unresectable or metastatic bladder cancer under priority review.
3 Dirt-Cheap Stocks That Could Skyrocket
11:23am, Tuesday, 05'th Dec 2023
Shares of China's e-commerce giant Alibaba continue to lose ground despite the company's clear top- and bottom-line growth. Pharmaceutical outfit Bristol-Myers Squibb has had a tough year.
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
09:46am, Wednesday, 29'th Nov 2023
The FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell therapy treatment. Therapies from NVS, BMY and GILD are under the spotlight.
Avidity Stock Soars on Collaboration Deal With Bristol Myers
07:43am, Tuesday, 28'th Nov 2023
Bristol Myers has agreed to pay Avidity $60 million in cash and will also purchase about $40 million of Avidity common stock at $7.88 a share.
Avidity Biosciences leaps on Bristol-Myers research tie-up
07:38am, Tuesday, 28'th Nov 2023
Avidity Biosciences soared 35% in pre-market trading after announcing a global licensing and research collaboration with Bristol-Myers Squibb Co (NYSE:BMY). The pact is focused on the discovery, dev
Bristol-Myers Squibb Is A Great Buy, But These 5+% Yielding Bargains Are Better
07:10am, Tuesday, 28'th Nov 2023
Bristol-Myers Squibb Company is down 40%, while the market is up 20%. The reason is the collapse in its growth outlook created by patent cliffs. Despite some amazing growth in new drugs, Bristol's thr
Avidity Biosciences Inc. RNA said Tuesday it's expanding its cardiovascular collaboration with Bristol Myers Squibb Co. BMY in a deal that will see Avidity receive $100 million upfront with the potent
3 Resilient Stocks with Massive Potential to Boost Your Wealth
04:43pm, Sunday, 26'th Nov 2023
Although the stock market whipsawed investors over the past few years, it showed its resilience by bouncing sharply higher after the pandemic collapse. As it has for more than a century, every double-
Don't Wait for a Market Crash: These 2 Top Stocks Are on Sale
05:30am, Friday, 24'th Nov 2023
When bad news happens to good companies, it just might be a signal to consider buying shares. Johnson Controls has a solid business, but its stock is down thanks to less-than-ideal guidance.
3 Tax-Loss Sell Alerts: These Stocks Likely To Fall By Even More
03:13pm, Wednesday, 22'nd Nov 2023
Investors should consider selling stocks with negative catalysts and at risk of further decline. Taxable account holders may realize losses to offset this year's capital gains. Avoid Companies with hi
Sign In
Buy BMY